SNC
ONCY

Stifel Nicolaus & Co’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Stifel Nicolaus & Co’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$130K Buy
53,366
+5,000
+10% +$13.8K ﹤0.01% 1420
2013
Q2 		$139K Buy
+48,366
New +$134K ﹤0.01% 1317

Other funds holding ONCY

AIM
Acuity Investment Management Toronto, Ontario, Canada $70.8M AUM 0.92% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
AII
AGF Investments Inc Toronto, Ontario, Canada $10.6B AUM 4.37% 1-Year Est. Return
AWMDMG
Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return
Canada Life
Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return

Stifel Nicolaus & Co's ONCY Position: Q3 2013 in Review

Stifel Nicolaus & Co increased its ONCOLYTICS BIOTECH INC (ONCY) stake by 10% in Q3 2013, buying an estimated $13.8K and bringing the position to 53,366 shares worth $130K. The position accounts for ﹤0.01% of the portfolio, ranked #1420.

Stifel Nicolaus & Co first reported a position in ONCY in Q2 2013 and has held it in 2 quarters since. The position peaked at $139K in Q2 2013. 39 funds tracked by Wall St. Rank hold ONCY as of Q3 2013.

  • Stifel Nicolaus & Co held 53,366 shares of ONCOLYTICS BIOTECH INC worth $130K as of Q3 2013.
  • Stifel Nicolaus & Co bought 5,000 ONCOLYTICS BIOTECH INC shares in Q3 2013, an estimated $13.8K.
  • ONCOLYTICS BIOTECH INC made up ﹤0.01% of Stifel Nicolaus & Co's portfolio in Q3 2013, its #1420 holding.
  • Stifel Nicolaus & Co first reported a position in ONCOLYTICS BIOTECH INC in Q2 2013 and has held it in 2 quarters since.
  • Stifel Nicolaus & Co's ONCOLYTICS BIOTECH INC position peaked at $139K in Q2 2013.
  • 39 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q3 2013.

Based on Stifel Nicolaus & Co's 13F filing for Q3 2013, filed 13 Nov 2013.